Loading
- publication . Article . 2016Open AccessAuthors:M.B. Schiavone; Vance Broach; Richard D. Carvajal; Nadeem R. Abu-Rustum; Nadeem R. Abu-Rustum; Marisa A. Kollmeier; Marisa A. Kollmeier; Mario M. Leitao; Mario M. Leitao; Kaled M. Alektiar; ...Publisher: Elsevier BVProject: NIH | MOUSE GENETICS (2P30CA008748-43)
Objective To report our experience using ipilimumab, a monoclonal antibody targeting CTLA-4, combined with radiation therapy in women diagnosed with mucosal melanoma of the lower genital tract. Methods We retrospectively identified all patients who received ipilimumab w...
- publication . Article . 2018Open AccessAuthors:Karen A. Cadoo; Karen A. Cadoo; Raanan Alter; Marina Stasenko; Mario M. Leitao; Mario M. Leitao; Vicky Makker; Vicky Makker; Jennifer J. Mueller; Jennifer J. Mueller; ...Publisher: Elsevier BVProject: NIH | MOUSE GENETICS (2P30CA008748-43)
Objective To report characteristics of patients with low-grade endometrioid endometrial carcinoma (EC) who develop brain metastases. Methods We retrospectively identified all patients treated at our institution for FIGO grades 1/2 EC from 1/2000–12/2016, who developed b...
- publication . Article . 2017Open Access EnglishAuthors:Sun Woo Kim; Sun Woo Kim; Dennis S. Chi; Dennis S. Chi; B. Margolis; B. Margolis;Publisher: ElsevierProject: NIH | MOUSE GENETICS (2P30CA008748-43)
Highlights • Pelvic exenteration can be used in patients with multifocal recurrence. • Ability to achieve negative margins remains a necessity for pelvic exenteration. • Individualized treatments are essential for those with recurrent malignancy.
- publication . Article . 2017Open Access EnglishAuthors:Darragh F. Halpenny; Carol Aghajanian; Vicky Makker; Gulisa Turashvili; Rachel N. Grisham; Madhuri Martin;Publisher: ElsevierProject: NIH | MOUSE GENETICS (2P30CA008748-43)
Highlights • Brain metastasis is an extremely rare secondary site of ovarian cancer metastasis. • Serous borderline tumor with brain metastasis has not been previously reported. • This is a rare case of brain metastasis in a patient with advanced serous borderline tumor...
- publication . Article . 2019Open Access EnglishAuthors:Carol Aghajanian; Vicky Makker; Karen Anne Cadoo; Maria M. Rubinstein; Darragh F. Halpenny; Rachel N. Grisham;Publisher: ElsevierProject: NIH | MOUSE GENETICS (2P30CA008748-43)
Highlights • Re-exposure to paclitaxel and carboplatin chemotherapy resulted in tumor shrinkage in 50% of women with endometrial cancer. • 15% of patients with recurrent endometrial cancer had stable disease upon re-exposure. • Re-using paclitaxel and carboplatin >6 mon...